Sinopharm International (02155.HK) releases half-year financial results with a net profit attributable to shareholders of 338 million yuan, a year-on-year decrease of 10.15%.
The Zhongtong Financial APP news announced that Sumsang International (02155.HK) released its interim performance for the six months ending June 30, 2025, with revenue of 2.687 billion yuan (RMB, same below), a decrease of 22.71% year-on-year; net profit attributable to shareholders was 0.338 billion yuan, a decrease of 10.15% year-on-year; basic earnings per share were 0.28 yuan.
Latest